TVTX – travere therapeutics, inc. (US:NASDAQ)
Stock Stats
News
How The Travere Therapeutics (TVTX) Story Is Shifting After FSGS Approval And Split Analyst Views [Yahoo! Finance]
A Look At Travere Therapeutics (TVTX) Valuation After FILSPARI's Landmark FDA Approval For FSGS [Yahoo! Finance]
Travere (TVTX) Soars 37.2%: Is Further Upside Left in the Stock? [Yahoo! Finance]
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Travere Therapeutics (TVTX) was upgraded by Piper Sandler from "neutral" to "overweight". They now have a $49.00 price target on the stock.
Form 4 Travere Therapeutics, For: Apr 14 Filed by: LYONS GARY A
Form 4 Travere Therapeutics, For: Apr 14 Filed by: Baynes Roy D.
Form 4 Travere Therapeutics, For: Apr 14 Filed by: Calvin Sandra
Form 4 Travere Therapeutics, For: Apr 13 Filed by: ROTE WILLIAM E.
Form 4 Travere Therapeutics, For: Apr 13 Filed by: Heerma Peter
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.